AIM
RXST icon

Aigen Investment Management’s RxSight RXST Stock Holding History

Aigen Investment Management’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-11,849
Closed -$407K – 996
2024
Q4 		$407K Buy
+11,849
New +$534K 0.07% 390
2024
Q3 		– Sell
-3,820
Closed -$230K – 975
2024
Q2 		$230K Sell
3,820
-4,962
-57% -$284K 0.04% 587
2024
Q1 		$453K Sell
8,782
-479
-5% -$23.5K 0.1% 306
2023
Q4 		$373K Sell
9,261
-10,837
-54% -$318K 0.07% 421
2023
Q3 		$561K Buy
+20,098
New +$599K 0.11% 315

Other funds holding RXST

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

Aigen Investment Management's RXST Position: Q1 2025 in Review

Aigen Investment Management sold out of RxSight (RXST) in Q1 2025, closing a stake of 11,849 shares — an estimated $407K sold.

Aigen Investment Management first reported a position in RXST in Q3 2023 and held it in 5 quarters. The position peaked at $561K in Q3 2023. 192 funds tracked by Wall St. Rank hold RXST as of Q1 2025.

  • Aigen Investment Management reported no remaining RxSight position as of Q1 2025 after selling out during the quarter.
  • Aigen Investment Management sold 11,849 RxSight shares in Q1 2025, an estimated $407K.
  • Aigen Investment Management first reported a position in RxSight in Q3 2023 and held it in 5 quarters.
  • Aigen Investment Management's RxSight position peaked at $561K in Q3 2023.
  • 192 funds tracked by Wall St. Rank held RxSight as of Q1 2025.

Based on Aigen Investment Management's 13F filing for Q1 2025, filed 12 May 2025.